Yao-Kuang Wang and colleagues has confirmed that EGCG can inhibit the proliferation and colony formation of arecoline-induced ESCC cells by inhibiting AKT and ERK1/2 pathway (105). This evidence concerns the gene AKT1 and esophageal squamous cell carcinoma.